>

Ressources

Retrouvez toutes les informations importantes sur notre industrie et le don de plasma ici. Vous trouverez des articles de haute qualité, fiables et remplis de faits et de réflexions intéressants.

Recherche de matériel

Liens rapides

Liens des membres

Quality Standards of Excellence, Assurance and Leadership (QSEAL)

Quality Standards of Excellence, Assurance and Leadership (QSEAL)

International Quality Plasma Program (IQPP)

International Quality Plasma Program (IQPP)

A missed opportunity to acknowledge EU’s dependency on U.S. plasma

A missed opportunity to acknowledge EU’s dependency on U.S. plasma

International Plasma Awareness Week 2022: Donate Locally. Think Globally.

International Plasma Awareness Week 2022: Donate Locally. Think Globally.

Liens des patients

North America Data program

North America Data program

Patient Notification System (PNS)

Patient Notification System (PNS)

Immunoglobulin Access Materials

Immunoglobulin Access Materials

Autres liens

PPTA 2025 Annual Report

PPTA 2025 Annual Report

PPTA Donor History Questionnaire

PPTA Donor History Questionnaire

National Donor Deferral Registry (NDDR®)

National Donor Deferral Registry (NDDR®)

Pathogen Safety

Pathogen Safety

Catégories

Fiches d'information

Les fiches d'information fournissent des informations supplémentaires sur l'industrie mondiale des protéines plasmatiques thérapeutiques.

Publications et présentations

Discover the main highlights of our industry in our latest publications.

Ressources pour les patients

Explorez les ressources de PPTA pour les patients intéressés par les thérapies aux protéines plasmatiques.

Rapports des parties prenantes

Apprenez-en plus en accédant à la collection de rapports de l'industrie.

Plaidoyer

Learn more about the Association's advocacy efforts to ensure patient access to therapies.

Actualités et communiqués de presse

Restez au courant de l'actualité et des événements de l'Association.

Accès aux soins

Discover a complete record of access to care issues by region and PPTA activities in support of access to therapies.

Articles de blog

Une compilation d'articles de blog

Sécurité et qualité

Apprenez-en davantage sur les politiques réglementaires et les normes volontaires de l'Association en matière de normes de sécurité et de qualité.

A Story of Alpha-1 Antitrypsin Deficiency: Dan Coffin's Journey of Finding Hope, One Plasma Donation at a Time

A Story of Alpha-1 Antitrypsin Deficiency: Dan Coffin's Journey of Finding Hope, One Plasma Donation at a Time

A Story of Alpha-1 Antitrypsin Deficiency: Dan Coffin's Journey of Finding Hope, One Plasma Donation at a Time

A Story of Alpha-1 Antitrypsin Deficiency: Dan Coffin's Journey of Finding Hope, One Plasma Donation at a Time

PPTA Statement on the Council’s negotiating mandate on the SoHO Regulation

PPTA statements

PPTA Statement on the Council’s negotiating mandate on the SoHO Regulation

PPTA Statement on the Council’s negotiating mandate on the SoHO Regulation

PPTA statements

PPTA Statement on the Council’s negotiating mandate on the SoHO Regulation

The Source Fall 2023

Magazine of the plasma protein therapeutics industry - Fall 2023

The Source Magazine

The Source Fall 2023

https://spaces.hightail.com/receive/bRmBuSpJRl

The Source Fall 2023

Magazine of the plasma protein therapeutics industry - Fall 2023

The Source Magazine

The Source Fall 2023

https://spaces.hightail.com/receive/bRmBuSpJRl

European Parliament Misses Opportunity to Increase Plasma Collection in Europe to Make Essential Medicines

PPTA statements

European Parliament Misses Opportunity to Increase Plasma Collection in Europe to Make Essential Medicines

European Parliament Misses Opportunity to Increase Plasma Collection in Europe to Make Essential Medicines

PPTA statements

European Parliament Misses Opportunity to Increase Plasma Collection in Europe to Make Essential Medicines

Aucun résultat n'a été trouvé